Ensysce Biosciences, Inc. ( ENSC) - Key Metrics
ENSC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.09 | -$0.20 | -$0.15 | -$0.15 |
| 2026Q1 | $0 | -$0.52 | -$0.51 | -$0.51 |
| 2025Q4 | $0 | -$1.08 | -$0.60 | -$0.60 |
| 2025Q3 | $0 | -$1.29 | -$0.65 | -$0.69 |
| 2025Q2 | $0 | -$0.79 | -$1.23 | -$1.23 |
ENSC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.36 |
| 2026Q1 | 0% | -0.26 |
| 2025Q4 | 0% | -0.31 |
| 2025Q3 | 0% | -0.46 |
| 2025Q2 | 0% | -0.71 |
ENSC
Price: $0.38
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.11 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 86482
Market Capitalization: 6.5 million